Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

Clinical trial NCT02500797 · COMPLETED

Trial details

NCT number: NCT02500797
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Bone Sarcoma Locally Advanced Dedifferentiated Liposarcoma Locally Advanced Gastrointestinal Stromal Tumor Locally Advanced Soft Tissue Sarcoma Metastatic Bone Sarcoma Metastatic Liposarcoma Metastatic Soft Tissue Sarcoma Metastatic Undifferentiated Pleomorphic Sarcoma Metastatic Unresectable Sarcoma Pleomorphic Liposarcoma Stage III Bone Sarcoma AJCC v7 Stage III Soft Tissue Sarcoma AJCC v7

Start date: 2015-08-13
Primary completion: 2019-04-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.